Literature DB >> 19153229

Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities.

Tracy J Ruckwardt1, Kathryn L Bonaparte, Martha C Nason, Barney S Graham.   

Abstract

In addition to regulating autoimmunity and antitumor immunity, CD4(+) CD25(+) FoxP3(+) natural regulatory T (Treg) cells are global regulators of adaptive immune responses. Depletion of these cells with the anti-CD25 antibody PC61 prior to primary respiratory syncytial virus (RSV) infection was partial but had several effects on the RSV-specific CD8(+) response in a hybrid mouse model. Mediastinal lymph node and spleen epitope-specific CD8(+) T-cell responses were enhanced in Treg-cell-depleted mice at all time points following infection, but responses of Treg-cell-depleted lung show a strikingly different pattern than lymphoid organ responses, with an initial delay in the CD8(+) T-cell response. The delay in the CD8(+) T-cell response correlated with a delay both in the early phase of viral clearance and in illness in Treg-cell-depleted mice compared to isotype-treated controls. The lungs of Treg-cell-depleted mice were shown to have increased lung chemokine and cytokine levels 7 days postinfection despite lower CD8(+) T-cell responses. Following the early delay in the lung response, CD8(+) T-cell responses at later infection time points were enhanced and increased the severity of illness in depleted mice. Finally, decreasing regulatory T-cell control of the CD8(+) T-cell response had a greater effect on response of the dominant K(d)-restricted M2 epitope consisting of amino acids 82 to 90 (K(d)M2(82-90)) than on the subdominant D(b)M(187-195) epitope response, indicating that regulatory T cells modulate immunodominance disparities in epitope-specific CD8(+) T-cell responses following primary RSV infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19153229      PMCID: PMC2655550          DOI: 10.1128/JVI.00036-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

Review 1.  The role of suppressor T cells in regulation of immune responses.

Authors:  Rebecca S McHugh; Ethan M Shevach
Journal:  J Allergy Clin Immunol       Date:  2002-11       Impact factor: 10.793

Review 2.  Role of Foxp3-positive regulatory T cells during infection.

Authors:  Yasmine Belkaid
Journal:  Eur J Immunol       Date:  2008-04       Impact factor: 5.532

Review 3.  Viral and host factors in human respiratory syncytial virus pathogenesis.

Authors:  Peter L Collins; Barney S Graham
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

4.  Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection.

Authors:  J Chang; A Srikiatkhachorn; T J Braciale
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

5.  Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract.

Authors:  Jun Chang; Thomas J Braciale
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

Review 6.  IL-2 signaling and CD4+ CD25+ Foxp3+ regulatory T cells.

Authors:  Laurence A Turka; Patrick T Walsh
Journal:  Front Biosci       Date:  2008-01-01

7.  Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.

Authors:  Kylie M Quinn; Fenella J Rich; Lisa M Goldsack; Geoffrey W de Lisle; Bryce M Buddle; Brett Delahunt; Joanna R Kirman
Journal:  Eur J Immunol       Date:  2008-03       Impact factor: 5.532

8.  CD8+ T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections.

Authors:  Jojanneke Heidema; Michaël V Lukens; Wendy W C van Maren; Mariska E A van Dijk; Henny G Otten; Adrianus J van Vught; Desiree B M van der Werff; Sjef J P van Gestel; Malcolm G Semple; Rosalind L Smyth; Jan L L Kimpen; Grada M van Bleek
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

9.  Coordination of early protective immunity to viral infection by regulatory T cells.

Authors:  Jennifer M Lund; Lianne Hsing; Thuy T Pham; Alexander Y Rudensky
Journal:  Science       Date:  2008-04-24       Impact factor: 47.728

10.  A role for immune complexes in enhanced respiratory syncytial virus disease.

Authors:  Fernando P Polack; Michael N Teng; Peter L Collins; Gregory A Prince; Marcus Exner; Heinz Regele; Dario D Lirman; Richard Rabold; Scott J Hoffman; Christopher L Karp; Steven R Kleeberger; Marsha Wills-Karp; Ruth A Karron
Journal:  J Exp Med       Date:  2002-09-16       Impact factor: 14.307

View more
  70 in total

1.  Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS.

Authors:  Maureen H Richards; Meghann Teague Getts; Joseph R Podojil; Young-Hee Jin; Byung S Kim; Stephen D Miller
Journal:  J Autoimmun       Date:  2011-01-26       Impact factor: 7.094

2.  Epitope-specific regulatory CD4 T cells reduce virus-induced illness while preserving CD8 T-cell effector function at the site of infection.

Authors:  Jie Liu; Tracy J Ruckwardt; Man Chen; John D Nicewonger; Teresa R Johnson; Barney S Graham
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

3.  Hepatitis B Virus Core Particles Containing a Conserved Region of the G Protein Combined with Interleukin-35 Protected Mice against Respiratory Syncytial Virus Infection without Vaccine-Enhanced Immunopathology.

Authors:  Jie Yang; Chen Ma; Yu Zhao; Anjing Fan; Xiufen Zou; Zishu Pan
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

4.  Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.

Authors:  Julian Schulze Zur Wiesch; Adriana Thomssen; Philip Hartjen; Ilona Tóth; Clara Lehmann; Dirk Meyer-Olson; Kristina Colberg; Sebastian Frerk; Dalia Babikir; Stefan Schmiedel; Olaf Degen; Stefan Mauss; Jürgen Rockstroh; Schlomo Staszewski; Pavel Khaykin; Alexander Strasak; Ansgar W Lohse; Gerd Fätkenheuer; Joachim Hauber; Jan van Lunzen
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

Review 5.  Tregs and infections: on the potential value of modifying their function.

Authors:  Sharvan Sehrawat; Barry T Rouse
Journal:  J Leukoc Biol       Date:  2011-09-13       Impact factor: 4.962

6.  Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells.

Authors:  Jens Loebbermann; Lydia Durant; Hannah Thornton; Cecilia Johansson; Peter J Openshaw
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

7.  PC61 (anti-CD25) treatment inhibits influenza A virus-expanded regulatory T cells and severe lung pathology during a subsequent heterologous lymphocytic choriomeningitis virus infection.

Authors:  Anke R M Kraft; Myriam F Wlodarczyk; Laurie L Kenney; Liisa K Selin
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

Review 8.  The Immune Fulcrum: Regulatory T Cells Tip the Balance Between Pro- and Anti-inflammatory Outcomes upon Infection.

Authors:  Laura E Richert-Spuhler; Jennifer M Lund
Journal:  Prog Mol Biol Transl Sci       Date:  2015-08-18       Impact factor: 3.622

9.  The chemokine MIP1alpha/CCL3 determines pathology in primary RSV infection by regulating the balance of T cell populations in the murine lung.

Authors:  John S Tregoning; Philippa K Pribul; Alasdair M J Pennycook; Tracy Hussell; Belinda Wang; Nicholas Lukacs; Jurgen Schwarze; Fiona J Culley; Peter J M Openshaw
Journal:  PLoS One       Date:  2010-02-24       Impact factor: 3.240

10.  IPS-1 is essential for the control of West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Daphne Y Ma; Sunil Thomas; Jennifer M Lund; Nu Zhang; Stephane Daffis; Alexander Y Rudensky; Michael J Bevan; Edward A Clark; Murali-Krishna Kaja; Michael S Diamond; Michael Gale
Journal:  PLoS Pathog       Date:  2010-02-05       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.